Skip to main content
. 2022 Sep 27;2022(9):CD014638. doi: 10.1002/14651858.CD014638.pub2

1.7. Analysis.

1.7

Comparison 1: Dexrazoxane versus no dexrazoxane or placebo, Outcome 7: Heart failure (i.e. clinical heart failure and subclinical myocardial dysfunction combined) worst‐case